Suppliers / Wuxi Kaili Pharmaceutical

Wuxi Kaili Pharmaceutical

China Updated 9 July 2026

Wuxi Kaili Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Yixing, China Not on file

What they file, and where

Molecule Regulators Docs
Eptifibatide US FDA 1

Also appears on these molecule pages

Eptifibatide API

Questions about Wuxi Kaili Pharmaceutical

Does Wuxi Kaili Pharmaceutical hold a US DMF or a CEP?
Wuxi Kaili Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Wuxi Kaili Pharmaceutical manufacture?
1 registered site is on record, in China (Yixing). Every site is listed on this page with the register it came from.
What does Wuxi Kaili Pharmaceutical make?
1 molecule is on record against Wuxi Kaili Pharmaceutical, including Eptifibatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Wuxi Kaili Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Alp Pharm Beijing shares 1 molecule PolyPeptide shares 1 molecule Hybio Pharmaceutical shares 1 molecule Sinopep-Allsino Biopharmaceutical shares 1 molecule Chengdu Shengnuo Biopharm shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability